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Summary
AIM OF STUDY: To report our experience of late correc-
tion after infancy in patients with tetralogy of Fallot (ToF).
METHODS: Observational single-centre retrospective
analysis of the surgical techniques and perioperative de-
velopment of patients from developing countries undergo-
ing total surgical correction of ToF after infancy, between
1 November 2011 and 30 November 2016. Variables are
presented as numbers with percentages or as mean ±
standard deviation. Due to the setting of the humanitarian
programme, clinical and echocardiographic follow-up pro-
cedures could be conducted for only one month postoper-
atively.
RESULTS: Twenty-five children (mean age: 70.8 ± 42
months, range 23-163; 44% female) underwent total surgi-
cal correction of ToF. Two patients (0.8%) initially received
a Blalock-Taussig shunt and underwent subsequent cor-
rection 24 and 108 months later, respectively. Preopera-
tive mean right ventricular/pulmonary artery (RV/PA) gra-
dient was 84 ± 32 mm Hg, with a Nakata index of 164 ± 71
mm2/m2. Major aortopulmonary collateral arteries (MAP-
CAs) were observed in eight children (32%), six (26%)
of whom underwent transcatheter closure before surgery.
24 children (96%) underwent a valve-sparing pulmonary
valve repair and one patient received a transannular patch
(TAP). There were no cases which saw major adverse car-
diac and cerebrovascular events (MACCE). Mean dura-
tion of mechanical ventilation was 28 ± 19.6 hours (range
7-76). Pre-discharge echocardiography demonstrated a
mean RV/PA gradient of 25 ± 5.7 mm Hg, with left ventric-
ular ejection fraction >60% in all cases. Overall length of
hospital stay was 11.7 ± 4.5 days. There were no in-hospi-
tal mortality cases.
CONCLUSIONS: Late surgical correction of ToF can be
safely performed and produce highly satisfying early post-
operative results comparable to those of classical “timely”
correction. A valve-sparing technique can be applied in the
majority of children.
Keywords: tetralogy of Fallot, congenital cardiac surgery,
perioperative outcome, late correction
Introduction
Usually, surgical correction of Tetralogy of Fallot (ToF) is
performed during infancy. The majority of paediatric car-
diac centres aim to achieve total correction by the age of
nine months [1–3]. According to recent analysis of the So-
ciety of Thoracic Surgeons’ congenital database, the peri-
operative mortality rate lies at 1.3% [4].
Early repair of ToF has many advantages: it reduces the
duration of hypoxaemia and its negative sequelae, such as
the development of cyanotic nephropathy, preserves my-
ocardial function, allows early normalisation of pulmonary
flow, which in turn stimulates angiogenesis in the pul-
monary vascular bed and supports lung growth [5]. In ad-
dition, chronic hypoxaemia, especially during the first year
of life, may result in cognitive and developmental delay.
ABBREVIATIONS:
BMI body mass index
BT Blalock Taussig
CHD congenital heart disease
ICU intensive care unit
CBT cardiopulmonary bypass time
CPB cardiopulmonary bypass
ICD implantable cardioverter defibrillator
LBBB left bundle branch block
MACCE major adverse cardiac and cerebrovascular events
MI myocardial infarction
MS median sternotomy
NIRS cerebral near-infrared spectroscopy
PS pulmonary stenosis
PV pulmonary valve
REDCap research electronic data capture
RV right ventricle
RV-PA conduit right ventricle to pulmonary artery conduit
RVOT right ventricle outflow tract
SD standard deviation
TAP transannular patch
TOE transoesophageal-echocardiography
ToF tetralogy of Fallot
URL upper reference limit
Correspondence:
Alexander Kadner, MD,
Centre for Congenital
Heart Disease, Department
of Cardiovascular Surgery,
Inselspital, Bern University
Hospital, University of
Bern, Freiburgstrasse 18,
CH-3010 Bern, alexan-
der.kadner[at]insel.ch
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 1 of 6
Due to the concomitant unrestrictive ventricular septal de-
fect and the stenosis of the right ventricle outflow tract
(RVOT), the right ventricle is chronically exposed to sys-
temic (or suprasystemic) pressure, resulting in right ven-
tricular hypertrophy with subsequent fibrosis, right ven-
tricular dysfunction and cardiac arrhythmias. Finally, early
repair decreases the psychosocial impact of the disease on
the child and family [2, 3, 6–8].
Contrary to practice in developed countries, patients in
developing countries usually do not receive timely repair
intervention. Less than 50% of the population in these
countries has access to health care facilities and for many
children suffering from ToF, the likelihood of receiving
corrective surgery is extremely low [9]. Many of these
children are diagnosed very late due to limited paediatric
medicine infrastructure and a lack of specialised medical
centres. Furthermore, in regions with a low socioeconomic
status, the majority of the population does not have health
insurance, this is particularly the case for children. Thus
therapy, diagnosis and intervention in particular, are be-
yond the reach of the average patient in these countries.
Furthermore, when medical centres do perform an (often
limited) number of corrective surgeries in children affected
by ToF, these operations are rarely performed during infan-
cy. Often, the affected patients and their families have to
live with the afore-mentioned negative sequelae for years.
A humanitarian programme, established by the centre for
congenital heart disease at the Inselspital Bern, has been
providing corrective congenital cardiac surgery for chil-
dren from developing countries for several years now. In
the context of this programme, late corrections of tetralogy
of Fallot (ToF) have been performed. Due to limited data
on late total repair, we investigated the surgical techniques,
perioperative development and short-term outcomes fol-
lowing late corrective surgery for ToF in children. This
information may be of interest to programmes offering
treatment to older children in developing nations or in in-
dustrialised countries as part of humanitarian programmes.
Methods
Patient selection and data collection
An observational retrospective single-centre study was
conducted using perioperative patient data retrieved from
clinical reports. All patients over the age of one year un-
dergoing corrective surgery for ToF at our centre between
1 November 2011 and 30 November 2016 were included.
An observational design following the STROBE statement
was used [10]. The Research Electronic Data Capture
(REDCap) system was used to record all data in a stan-
dardised database.
Patient characteristics, procedural data and outcomes are
shown in tables 1-3. All statistical calculations were per-
formed using Stata 12 (College Station, Texas). Parameters
are presented as numbers with percentage or as mean ±
standard deviation.
Definition of major adverse cardiac and cerebrovascu-
lar events
Major adverse cardiac and cerebrovascular events (MAC-
CE) were defined as sudden cardiac death, myocardial in-
farction (MI), cardiac arrhythmias needing intervention in
the form of permanent pacemaker implantation, neurolog-
ical complications or renal failure requiring replacement
therapy. Myocardial infarction was defined according to
the 2012 Third Universal Definition of Myocardial Infarc-
tion by the European Society of Cardiology Guidelines as
elevation of cardiac high-sensitive troponin (hs-TnT) >10
x 99th percentile URL in patients with normal baseline hs-
TnT levels. In addition, the following were considered in-
dicative of MI [11]:
– new pathological Q-waves
– new left bundle branch block (LBBB)
– angiographically documented new native coronary
artery occlusion
Table 1: Preoperative demographics.
Mean/% SD Range
Number of patients 25
Male (%) 56%
Female (%) 44%
Age (months, mean) 70.8 ±42 23–163
Weight (kg, mean) 17.7 ±10.2 9.0–53.9
Height (cm, mean) 107 ±23 77–167
BMI (kg/m2, mean) 14.6 ±1.9 10.9–19.3
CT index, mean 0.6 ±0.1 -
Peripheral O2 saturation (%, mean) 84 ±12.2 55–99
Preoperative echocardiography
Presence of ASD (%) 18 (70%)
Aberrant coronary artery (%) 7 (40%)
RV/PA gradient (mm Hg) 84.3 ±31.6 40–180
PV diameter (mm) 11.6 ±2.9 8–18
PV Z score −1.9 ±1.6
LPA diameter (mm) 8.7 ±2.4 5–13
LPA Z score −0.05 ±1.27 −2.49–2.37
RPA diameter (mm) 8.1 ±2.8 4–14
RPA Z score −1.32 ±1.41 −3.74–1.30
Nakata index 163.6 ±70.5 66–321
BMI = body mass index; ASD = atrial septal defect; LPA = left pulmonary artery; PA = pulmonary artery; PV = pulmonary valve; RPA = right pulmonary artery; RV = right ventricle
Parameters are presented as percentages or as mean ± standard deviation and range.
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– imaging evidence of new loss of viable myocardium
– new regional wall motion abnormality.
Anaesthesia and surgical technique
Patients received general anaesthesia with endotracheal in-
tubation after induction with sevoflurane, sufentanil and
rocuronium. Intraoperative monitoring employed Ameri-
can Society of Anesthesiologists (ASA) standard monitor-
ing tools, as well as invasive monitoring of arterial blood
pressure and central venous pressure, nasopharyngeal tem-
perature and urine output. Additionally, transoesophageal-
echocardiography (TOE) and cerebral near-infrared spec-
troscopy (NIRS) were used in all cases.
All patients underwent median sternotomy and standard
aortic and bi-caval cannulation. Cardiopulmonary bypass
(CPB) was conducted in a state of mild hypothermia. The
aorta was cross-clamped and antegrade cardioplegia was
administered, using a low-dose (1.5 ml/kg), single-shot
crystalloid solution (Cardioplexol™, Bichsel, Switzerland)
[12]. In case of significant backflow from major aortopul-
monary collateral arteries (MAPCA), moderate hypother-
mia was induced and the flow reduced accordingly. In
children with modified Blalock-Taussig (BT) shunt, shunt
takedown was performed at the time of the ToF correction.
Closure of the ventricular septal defect (VSD) was per-
formed either using a transatrial approach or through a
right ventricular outflow tract (RVOT) incision in case of a
RVOT enlargement by patch plasty.
For pulmonary valve management, a valve-sparing ap-
proach was preferred, applying commissurotomy and
shaving of the leaflets in the majority of patients. Thus, the
drawbacks related to RVPA conduits, such as multiple re-
interventions and an elevated risk of endocarditis, could be
avoided. This is of particular interest for children from de-
veloping countries. The transvalvular pressure gradient be-
tween RV and PA was always invasively assessed follow-
ing weaning from CPB.
Postoperative management
Postoperative management was performed according to
standard operating procedures for ToF. Patients were dis-
charged from hospital and transferred to a specialised pae-
diatric care centre operated by the non-governmental or-
ganization Terre des Hommes. From there, the children
ultimately returned to their country of origin. Follow-up
procedures included clinical examination and echocardio-
graphy by board-certified paediatric cardiologists. Due to
the setting of the humanitarian programme, clinical and
echocardiographic follow-up could be conducted for only
one month postoperatively, before the patients returned to
their country of origin.
Results
Demographics
A series of 25 children (44% female) underwent total cor-
rection of ToF as part of this study. Their mean age was
70.8 ± 42 months and their mean weight was 17.7 ± 10.2
kg (range 9–53.9), with a BMI of 14.6 ± 1.9 kg/m2 (range
10.9–19.3). Preoperative oxygen saturation was 84 ±
Table 2: Intraoperative data and surgical procedures.
Mean/% SD / n Range
Perfusion Cardiopulmonary bypass time (min) 93.0 ±22 35–140
Aortic cross-clamp time (min) 56.0 ±15 21–93
Core temperature nadir (°C) 30.6 ±2.1 25–32
Surgical technique Valve-sparing approach 96% 24
Transannular patch plasty 4% 1
Concomitant procedures Subvalvular patch plasty 72% 18
Supravalvular patch plasty 72% 18
RVOT enlargement 100% 25
Valvulotomy 63% 16
VSD patch closure 100% 25
ASD direct closure 72% 18
ASD = atrial septal defect; RVOT = right ventricular outflow tract; VSD = ventricular septal defect Parameters are presented as percentages or as mean ± standard deviation and
range.
Table 3: Postoperative characteristics.
Mean/% SD Range
ICU Mechanical ventilation (hours) 28.7 ±19.6 7–76
ICU stay (days) 4.8 ±2.35 2–10
Postoperative 02 saturation 1.0 ±0.01 0.95–1
Hospital stay (days) 11.7 ±4.54 4–25
Mortality 0%
MACCE Sudden cardiac death (%) 0%
Myocardial infarction (%) 0%
Cardiac arrhythmias needing intervention (%) 0%
Neurological complications (%) 0%
Renal failure requiring RRT (%) 0%
Adverse outcomes Budd-Chiari syndrome (%) 4%
Endocarditis (%) 4%
OR = operating room; ICU = intensive care unit; MACCE = major adverse cardiac and cerebrovascular events, RRT = renal replacement therapy Parameters are presented as
percentages or as mean ± standard deviation and range.
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12.2%. The calculated Nakata index was 164 ± 71
mm2/m2. MAPCAs were observed in eight cases (32%)
and in six of these (26%), patients underwent preoperative
interventional closure. Additional preoperative demo-
graphics are summarised in table 1.
Operative data
In all patients (n = 24) a valve-sparing approach was ini-
tially performed, using commissurotomy and leaflet shav-
ing. Subvalvular patch plasty was performed in 72% (n =
18) and supravalvular patch plasty in 72% (n = 18), while a
transannular patch plasty (TAP) was performed in one pa-
tient. VSD patch closure using xenopericardium tissue was
performed in all patients. All patients underwent RVOT
enlargement by subvalvular extensive resection of hyper-
trophic myocardial tissue.
Mean total CPB time was 93 ± 22 min (range 35-140),
with a mean aortic cross-clamp time of 56 ± 15 min (range
21–93). The mean temperature on CPB was 30.6 ± 2.1°C.
It had been necessary to lower the temperature to less than
30°C in seven patients (28%) to manage non-coronary col-
lateral flow from significant MAPCA vessels.
Following CPB weaning, the intraoperative RV-to-PA gra-
dient was invasively measured by direct needle transduc-
tion and demonstrated a transvalvular gradient of 34.6 ±
14.8 mm Hg. Intraoperative characteristics are summarised
in table 2.
Postoperative course
Postoperative data are summarised in table 3. Mechanical
ventilation lasted 28.7 ± 19.6 hours (range 7–76). Length
of high-dependency unit (ICU, IMC) stay was 4.8 ± 2.4
days (range 2–10) and total length of hospital stay was
11.7 ± 4.5 days (range 4–25). There was no occurrence of
MACCE. There was no in-hospital mortality.
Budd-Chiari syndrome occurred in a 27-month-old girl af-
ter surgery, requiring longer ICU care (10 days) and con-
sequent discharge from hospital after 25 days. Surgical re-
intervention was necessary in two cases. In the first case,
the patient underwent reoperation due to significant resid-
ual RVOT stenosis. In the second case, the patient was re-
ferred for treatment due to endocarditis of the PV three
weeks after corrective surgery, necessitating implantation
of a right ventricle-to-pulmonary artery (RV-PA) conduit
(20mm Contegra®, Medtronic, USA). The remaining post-
operative development of both patients was uneventful
thereafter.
Follow-up echocardiography for all patients one month
postoperatively demonstrated a residual mean gradient
over the RVOT of 25 ± 5.7 mm Hg, normal biventricular
function in all cases and oxygen saturation of 98% (range
95–100%).
A residual pulmonary valve stenosis (PS) was trivial in
48% (n = 12) and moderate in 16% (n = 4). A moderate
residual subvalvular PS was observed in 12% (n = 3). A
trivial residual supravalvular PS was noticed in 20% (n =
5) and moderate in 8% (n = 2). Pulmonary valve insuffi-
ciency was trivial in 44% (n = 11) and moderate in 8% (n
= 2) of patients.
Discussion
Correction of ToF is part of the standard spectrum of con-
genital cardiac surgery. In recent decades, excellent results
have been reported, with low morbidity and mortality
rates. There is general consensus that the recommended pa-
tient age for correction is during infancy, with most pa-
tients undergoing surgery between six and nine months of
age [1–3]. The current correction strategy emphasises a
valve-sparing approach. This often creates a mild resid-
ual stenosis due to the hypoplastic pulmonary valve to-
gether with a mild insufficiency as a result of valvular
commissurotomy, but has the advantage of preserving the
pulmonary annulus, while enlargement of the hypoplastic
pulmonary artery and of the RVOT is possible through
patch plasty. Several groups advocate a strategy which pre-
serves the pulmonary annulus. This would also maximize
the preservation of valve function over the long term, even
if the effect of these strategies on the long-term function of
the right ventricle and pulmonary valve remain unknown
[4, 13, 14].
This study reports the results obtained in a small number
of ToF-affected children who were operated on at a mean
age of 71 months. This is older than usually reported [15].
The oldest patients who benefitted from total ToF correc-
tion (without a previous BT shunt) were even older than 10
years of age. The mean BMI was 14.6 ± 1.9 kg/m2 (range
10.9–19.3) and the mean weight was 17.7 ± 10.2 kg (range
9–53.9). These were associated with chronic malnutrition,
hypoxia and growth retardation [7]. Malnutrition is com-
mon in children with congenital heart disease (CHD) and
studies from developed countries have documented nor-
malisation of somatic growth when corrective surgery for
CHD is performed early [16]. It is also known that 25% of
children have persistent malnutrition even after corrective
intervention, especially if the correction is performed late
[16].
Other characteristics included the higher percentage (32%)
of MAPCAs in the paediatric population with ToF com-
pared to the international average (2%) [17]. This finding
can be explained by the response to the chronically de-
creased pulmonary blood flow and cyanosis [8, 17]. This is
well-recognised, since the percentage of MAPCAs in un-
treated adults is between 13% and 25%, but unlikely to
occur at all in patients who received correction before six
months of age [8, 17]. In addition, MAPCAs can result in a
number of complications, including gross enlargement and
erosion of the bronchi, massive haemoptysis, postoperative
pulmonary oedema and prolongation of postoperative me-
chanical ventilation and ICU stay [17]. In this study, 26%
of the treated children underwent transcatheter closure just
prior to surgical correction to avoid complications. By fol-
lowing this strategy, it was possible to successfully manage
intraoperative collateral vessels and postoperative therapy.
A more frequent occurrence of coronary abnormality was
found compared to the international average for patients
with ToF [18].
Regarding mortality after ToF correction, the Society of
Thoracic Surgeons Database reports a rate of 7.5% at dis-
charge after palliation with a BT shunt, 0.9% after a total
repair with a previous palliation and 1.3% following cor-
rection without a previous shunt [4]. However, the patients
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in our study were significantly older than the international
mean age at total repair surgery.
Benbrik compared patients from developing countries
(mean age of 57.6 ± 38 months) who underwent total
correction of ToF, with a control population from an in-
dustrialised country (mean age: 8.3 ± 9.1 months) who
underwent timely complete repair of ToF. He reported a
mortality rate of 4.2%, with no difference between the
groups [15]. Another study by Raj reported a 2% mortality
rate after late total correction of ToF [19]. In our study pop-
ulation there was no perioperative mortality. This confirms
that even late repair of ToF can be accomplished with a low
mortality rate.
Another important point to note when evaluating repair
strategies, is the management of the pulmonary valve. It is
well recognized that a total repair of ToF, even if associat-
ed with a certain degree of pulmonary stenosis, should aim
to preserve the native pulmonary valve [4, 13]. Stewart re-
ported on a pulmonary valve-sparing approach for the re-
pair of tetralogy of Fallot. The group identified significant
markers for success, including a measured pulmonary an-
nulus z score of negative 4 or greater and the existence of
a tricuspid pulmonary valve [20]. In our study group, the
mean preoperative pulmonary annulus z score was −1.9 ±
1.6, and a tricuspid pulmonary valve was found in in 24
patients (96%), all of whom were operated on with a pul-
monary valve-sparing approach.
The valve-sparing procedure may preserve the integrity of
the pulmonary valve. Conversely, liberal application of a
transannular patch increases the incidence of pulmonary
regurgitation, persistent RV hypertension and chronic RV
volume loading. In addition, a short-term benefit of the
valve-sparing procedure is the shorter duration of mechan-
ical ventilation compared with patients who receive a
transannular patch (TAP) [14].
Benbrik performed a TAP in 35% of patients, with the
same percentage in both developing-country and control
groups [15]. Raj et al. found that a native valve could be
preserved in only 30% of their patients [19]. In some cas-
es, a valve-sparing approach might be impossible due to a
highly hypoplastic PV. However, both studies also report-
ed a percentage of TAP among patients who underwent
“timely” correction. We were able to perform a valve-spar-
ing correction in 24 patients (96%) by applying the above-
listed techniques in the majority of our patients. However,
this might have been made possible by favourable charac-
teristics of our patients. Further follow-up is mandatory in
order to demonstrate whether the valve-sparing strategy is
advantageous when mid- to long-term PV and RV develop-
ment and function are considered in this patient population
[21].
As stated above, the duration of mechanical ventilation is
shorter when patients are subjected to a valve-sparing pro-
cedure than when they undergo TAP placement [14]. In
our cohort, the ICU stay was 4.8 ± 2.4 days within a total
hospital length of stay (LOS) of 11.7 ± 4.5 d. The mean
duration of mechanical ventilation was 28.7 ± 19.6 h. At
the beginning of our work as part of the humanitarian pro-
gramme, we were cautious with early extubation due to
the limited experience with these specific patients. Subse-
quently, ventilation time was reduced, even leading to fast-
track extubation in selected patients.
The length of time of mechanical ventilation varies among
published studies. Hirsch et al. reported an average dura-
tion of 163.2 hours of mechanical ventilation after a com-
plete repair of ToF in neonates [22].
Benbrik et al., while comparing patients from developing
and industrialised countries, observed a mechanical venti-
lation duration of 48 ± 89h (developing) vs 67 ± 97 h (in-
dustrialised), with an ICU stay of 93 ± 81h (vs172 ± 329h)
and a total length of stay of 11 ± 6d vs 15 ± 15 d. They
concluded that older patients tended to experience shorter
durations of mechanical ventilation, stays in the ICU and
stays in hospital [15].
Raj reported mechanical ventilation lasting 34 ± 28h and
ICU LOS of 6.86 ± 6.32d as part of a total hospital LOS of
11.8 ± 6d [19]. Our late-repair cohort does well in compar-
ison with these data, with a mean duration of mechanical
ventilation of 29 hours, an average ICU stay of 4.8 days
and a mean hospital stay of 11.7 days. From the literature
and our own experience, there appeared to be no need for
prolonged ventilation or extended length of stay in older
ToF patients. We therefore established postoperative fast-
track protocols during the later stages of our collaboration.
The only exception was our patient with Budd Chiari syn-
drome, who required prolonged ICU and hospital stays.
The outcome after total repair of ToF is determined by sev-
eral factors, the most important of which appears to be
postoperative RV function [23]. Due to advanced RV hy-
pertrophy in late repair candidates, restrictive RV dysfunc-
tion may be present [15]. Even today, conclusive informa-
tion is lacking on the optimal surgical strategy for primary
repair, with the aims being the preservation of RV function,
reduction of arrhythmogenicity and optimisation of func-
tional status [24]. After ToF repair, biventricular systolic
function is usually normal, but RV diastolic function may
be impaired to the extent that it requires close surveillance
[24, 25]. At this stage in our study, we only have echocar-
diography data on early postoperative RV systolic and di-
astolic function, which was good in all patients. Long-term
follow-up is needed, with echocardiographic assessment of
the RV.
Late correction of ToF can be safely performed in older
children with excellent early postoperative results and low
mortality and morbidity comparable to results reported for
timely correction in infants. A valve-sparing correction
should be considered for those patients. Follow-up inves-
tigation of the development of right ventricular and pul-
monary valve dysfunction is urgently needed and is cur-
rently under way.
This study has several limitations. It is a retrospective sin-
gle-centre observational analysis, therefore cause and ef-
fect are hard to establish. Selection bias is possible, since
most of these children have survived early infancy without
surgical palliation, correction or even appropriate medical
management, which indicates less severe ToF pathology.
Furthermore, our cohort size was small, obviating robust
conclusions on outcomes like perioperative mortality. Fol-
low-up and cardiac function assessment were carried out
using echocardiography only. MRI studies would have
been preferable but financial restrictions on this humani-
tarian programme meant that this was not possible.
Original article Swiss Med Wkly. 2019;149:w20096
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 5 of 6
Acknowledgments
The authors would like to thank Jeannie Wurz, medical editor at the
Department of Anaesthesiology and Pain Medicine, Bern University
Hospital, for her careful editing of the manuscript.
Disclosure statement
No financial support and no other potential conflict of interest relevant
to this article was reported.
References
1 Steiner MB, Tang X, Gossett JM, Malik S, Prodhan P. Timing of com-
plete repair of non-ductal-dependent tetralogy of Fallot and short-term
postoperative outcomes, a multicenter analysis. J Thorac Cardiovasc
Surg. 2014;147(4):1299–305. doi: http://dx.doi.org/10.1016/
j.jtcvs.2013.06.019. PubMed.
2 Van Arsdell GS, Maharaj GS, Tom J, Rao VK, Coles JG, Freedom RM,
et al. What is the optimal age for repair of tetralogy of Fallot? Circula-
tion. 2000;102(19, Suppl 3):III123–9. doi: http://dx.doi.org/10.1161/
01.CIR.102.suppl_3.III-123. PubMed.
3 Parry AJ, McElhinney DB, Kung GC, Reddy VM, Brook MM, Hanley
FL. Elective primary repair of acyanotic tetralogy of Fallot in early in-
fancy: overall outcome and impact on the pulmonary valve. J Am Coll
Cardiol. 2000;36(7):2279–83. doi: http://dx.doi.org/10.1016/
S0735-1097(00)00989-X. PubMed.
4 Al Habib HF, Jacobs JP, Mavroudis C, Tchervenkov CI, O’Brien SM,
Mohammadi S, et al. Contemporary patterns of management of tetralogy
of Fallot: data from the Society of Thoracic Surgeons Database. Ann
Thorac Surg. 2010;90(3):813–9, discussion 819–20. doi:
http://dx.doi.org/10.1016/j.athoracsur.2010.03.110. PubMed.
5 Tamesberger MI, Lechner E, Mair R, Hofer A, Sames-Dolzer E, Tulzer
G. Early primary repair of tetralogy of fallot in neonates and infants less
than four months of age. Ann Thorac Surg. 2008;86(6):1928–35. doi:
http://dx.doi.org/10.1016/j.athoracsur.2008.07.019. PubMed.
6 Tchoumi JCT, Ambassa JC, Giamberti A, Cirri S, Frigiola A, Butera G.
Late surgical treatment of tetralogy of Fallot. Cardiovasc J Afr.
2011;22(4):179–81. doi: http://dx.doi.org/10.5830/CVJA-2010-057.
PubMed.
7 Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mecha-
nisms of development and progression of cyanotic nephropathy. Pediatr
Nephrol. 2006;21(10):1440–5. doi: http://dx.doi.org/10.1007/
s00467-006-0220-5. PubMed.
8 Derby CD, Pizarro C. Routine primary repair of tetralogy of Fallot in the
neonate. Expert Rev Cardiovasc Ther. 2005;3(5):857–63. doi:
http://dx.doi.org/10.1586/14779072.3.5.857. PubMed.
9 Kumar RK, Tynan MJ. Catheter interventions for congenital heart dis-
ease in third world countries. Pediatr Cardiol. 2005;26(3):241–9. doi:
http://dx.doi.org/10.1007/s00246-005-1005-5. PubMed.
10 Bastuji-Garin S, Sbidian E, Gaudy-Marqueste C, Ferrat E, Roujeau J-C,
Richard M-A, et al.; European Dermatology Network (EDEN). Impact
of STROBE statement publication on quality of observational study re-
porting: interrupted time series versus before-after analysis. PLoS One.
2013;8(8):. doi: http://dx.doi.org/10.1371/journal.pone.0064733.
PubMed.
11 Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, White HD, Joint ESC/
ACCF/AHA/WHF Task Force for the Universal Definition of Myocar-
dial Infarction, et al. Third universal definition of myocardial infarction.
Circulation, vol. 126, American Heart Association, Inc; 2012, pp.
2020–35. doi: http://dx.doi.org/10.1161/CIR.0b013e31826e1058. .
12 Kairet K, Deen J, Vernieuwe L, de Bruyn A, Kalantary S, Rodrigus I.
Cardioplexol, a new cardioplegic solution for elective CABG. J Cardio-
thorac Surg. 2013;8(S1):P120. doi: http://dx.doi.org/10.1186/
1749-8090-8-S1-P120.
13 Bacha E. Valve-Sparing or Valve Reconstruction Options in Tetralogy of
Fallot Surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu.
2017;20:79–83. doi: http://dx.doi.org/10.1053/j.pcsu.2016.09.001.
PubMed.
14 Sen DG, Najjar M, Yimaz B, Levasseur SM, Kalessan B, Quaegebeur
JM, et al. Aiming to Preserve Pulmonary Valve Function in Tetralogy of
Fallot Repair: Comparing a New Approach to Traditional Management.
Pediatr Cardiol. 2016;37(5):818–25. doi: http://dx.doi.org/10.1007/
s00246-016-1355-1. PubMed.
15 Benbrik N, Romefort B, Le Gloan L, Warin K, Hauet Q, Guerin P, et al.
Late repair of tetralogy of Fallot during childhood in patients from de-
veloping countries. Eur J Cardiothorac Surg. 2015;47(3):e113–7. doi:
http://dx.doi.org/10.1093/ejcts/ezu469. PubMed.
16 Vaidyanathan B, Radhakrishnan R, Sarala DA, Sundaram KR, Kumar
RK. What determines nutritional recovery in malnourished children after
correction of congenital heart defects? Pediatrics. 2009;124(2):e294–9.
doi: http://dx.doi.org/10.1542/peds.2009-0141. PubMed.
17 Sadiq N, Ullah M, Mahmoud A, Akhtar K, Younis U. Perioperative Ma-
jor Aortopulmonary Collateral Arteries (MAPCAs) Coiling in Tetralogy
of Fallot Patients Undergoing for Total Correction. J Cardiol Curr Res.
2015;3:00123. doi: http://dx.doi.org/10.15406/jccr.2015.03.00123.
18 Mosca RS. Tetralogy of Fallot: Total Correction. Oper Tech Thorac Car-
diovasc Surg. 2002;7(1):22–8. doi: http://dx.doi.org/10.1053/
otct.2002.32310.
19 Raj R, Puri GD, Jayant A, Thingnam SKS, Singh RS, Rohit MK. Peri-
operative echocardiography-derived right ventricle function parameters
and early outcomes after tetralogy of Fallot repair in mid-childhood: a
single-center, prospective observational study. Echocardiography.
2016;33(11):1710–7. doi: http://dx.doi.org/10.1111/echo.13333.
PubMed.
20 Stewart RD, Backer CL, Young L, Mavroudis C. Tetralogy of Fallot: re-
sults of a pulmonary valve-sparing strategy. Ann Thorac Surg.
2005;80(4):1431–8, discussion 1438–9. doi: http://dx.doi.org/10.1016/
j.athoracsur.2005.04.016. PubMed.
21 Balasubramanya S, Zurakowski D, Borisuk M, Kaza AK, Emani SM,
Del Nido PJ, et al. Right ventricular outflow tract reintervention after
primary tetralogy of Fallot repair in neonates and young infants. J Tho-
rac Cardiovasc Surg. 2018;155(2):726–34. doi: http://dx.doi.org/
10.1016/j.jtcvs.2017.09.019. PubMed.
22 Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot
in the neonate: results in the modern era. Ann Surg.
2000;232(4):508–14. doi: http://dx.doi.org/10.1097/
00000658-200010000-00006. PubMed.
23 Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock
JE, et al. Ventricular size and function assessed by cardiac MRI predict
major adverse clinical outcomes late after tetralogy of Fallot repair.
Heart. 2008;94(2):211–6. doi: http://dx.doi.org/10.1136/
hrt.2006.104745. PubMed.
24 Villafañe J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin
AM, et al.; Adult Congenital and Pediatric Cardiology Section, Ameri-
can College of Cardiology. Hot topics in tetralogy of Fallot. J Am Coll
Cardiol. 2013;62(23):2155–66. doi: http://dx.doi.org/10.1016/
j.jacc.2013.07.100. PubMed.
25 Sachdev MS, Bhagyavathy A, Varghese R, Coelho R, Kumar RS. Right
ventricular diastolic function after repair of tetralogy of Fallot. Pediatr
Cardiol. 2006;27(2):250–5. doi: http://dx.doi.org/10.1007/
s00246-005-1186-y. PubMed.
Original article Swiss Med Wkly. 2019;149:w20096
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 6 of 6
